{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion requires the response to state that management being located in the UK (rather than the Netherlands) could avoid potential issues associated with the Dutch CV (PE and PPT). The candidate answer analyzes the PE risk based on the UK LP (as general partner) exercising management/decision-making in the Netherlands, which *creates* the PE risk (dependent agent PE in NL). The recommendations focus on *moving* management/substance to the Netherlands (appointing a Dutch GP, adding Dutch substance) to *mitigate* the risk and satisfy the PPT. The answer does not suggest that management being in the UK *avoids* the issues; rather, it implies that the UK LP's management role *causes* the issues (PE in NL, and potential PPT failure because the structure is a conduit back to the UK). Therefore, the specific assertion required by the criterion is not present.\", \"criterion_id\": \"e1522b6a-f03f-477e-acad-a08fa97db3b2\"}", "usage": {"prompt_tokens": 3659, "completion_tokens": 229, "total_tokens": 3888}, "latency_s": 1.0357755420263857, "request_id": "yeWUacNStPjGzQ-r-pnhAg", "raw_response": null}